|
WO2021064214A1
|
|
System for the automatic evaluation of cognition and consciousness of an individual through external stimulations
|
|
WO2020152212A1
|
|
Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions
|
|
WO2020127940A1
|
|
System and method to measure and monitor neurodegeneration
|
|
WO2020084168A1
|
|
Tetracycline compound for treating drug-induced dyskinesia
|
|
WO2020053280A1
|
|
System and methods for consciousness evaluation in non-communcating subjects
|
|
US2020077918A1
|
|
System and methods for consciousness evaluation in non-communicating subjects
|
|
US2019366033A1
|
|
System for bilateral in-ear eeg recording with closed-loop binaural sensory stimulation
|
|
US2018110742A1
|
|
Nmda antagonists for the treatment of mental disorders with occurrence of aggressive and/or impulsive behavior
|
|
WO2018073248A1
|
|
Prognosis of demyelinating diseases patients and treatment thereof
|
|
US2017368348A1
|
|
Method and device for enhancing memory consolidation
|
|
EP3013355A1
|
|
Il-2 for use in treating alzheimer disease and related disorders
|
|
WO2013139931A1
|
|
Composition for use in the treatment of neurodegenerative diseases with parkinsonian syndromes
|
